NCT04079257View on ClinicalTrials.gov

The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Paroxysmal Nocturnal HemoglobinuriaEculizumabPK-PD
Interventions
OTHER

Blood collection for measurement of eculizumab peak concentrations

collection of blood

Trial Locations (1)

Unknown

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04079257 - The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria | Biotech Hunter | Biotech Hunter